Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDUCE: Prophylactic Haloperidol for Delirium in ICU Patients
NCT01785290Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of haloperidol in delirium, sponsored by Radboud University Medical Center. Started Jun 2013; status: completed.
02
Drugs
haloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on NCT01785290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01785290.